摘要
第16届圣加伦(St.Gallen)国际乳腺癌会议于2019年3月20日—3月23日在奥地利维也纳盛大召开,两年一度的St.Gallen国际乳腺癌会议与专家共识对过去两年来乳腺癌领域所出现的新的治疗证据进行盘点和总结。今年大会的主题是“评估早期乳腺癌(EBC)治疗方案的临床获益”。会议主要针对早期乳腺癌外科治疗、内科治疗、放射治疗等热点以及具有争议的话题展开热烈的讨论,并最终形成了专家共识。本文就内科治疗的热点问题(HER2阳性早期乳腺癌部分)作一解读。
The 16th St.Gallen International Breast Cancer Conference was held in Vienna,Austria from March 20,2019 to March 23,2019.The biennial St.Gallen International Breast Cancer Conference and Expert Consensus present an inventory and summary of the progress of breast cancer treatment over the past two years.The theme of this conference is"assessing the clinical benefits of early breast cancer(EBC)treatment".The meeting mainly focused on the hot topics of surgical treatment,medical treatment and radiotherapy for early breast cancer,as well as controversial topics,and finally formed an expert consensus.The paper presents an overview of the hot issues(HER2 positive early breast cancer)reflected in this conference.
作者
郑亚兵
俞洋
王晓稼
ZHENG Yabing;YU Yang;WANG Xiaojia(Department of Medical Oncology,Cancer Hospital of University of Chinese Academy of Science(Zhejiang Cancer Hospital),Hangzhou 310022,China;Department of Breast Surgery,Cancer Hospital of University of Chinese Academy of Science(Zhejiang Cancer Hospital),Hangzhou 310022,China)
出处
《肿瘤防治研究》
CAS
CSCD
2019年第12期1053-1056,共4页
Cancer Research on Prevention and Treatment
基金
浙江省科技厅公益技术应用研究计划项目（2016C33119）
浙江省医药卫生平台计划项目（2016RCA003）
关键词
乳腺癌
治疗
共识
解读
Breast cancer
Treatment
Consensus
Interpretation
